Issue 30, 2012

Synthesis and evaluation of new polyenic compounds as potential PPARs modulators

Abstract

In order to identify new leads for the treatment of type 2 diabetes, polyenic molecules A and B derived from nipecotic acid and dienol derivatives C have been prepared and their effect on PPARs transcriptional activity evaluated and compared to that of rosiglitazone, WY14,643 and GW501516. Among the synthesized compounds, dienol 39 is the most active, increasing WY14,643 PPARα response and demonstrating partial agonist properties on rosiglitazone PPARγ.

Graphical abstract: Synthesis and evaluation of new polyenic compounds as potential PPARs modulators

Supplementary files

Article information

Article type
Paper
Submitted
21 mar 2012
Accepted
02 apr 2012
First published
03 apr 2012

Org. Biomol. Chem., 2012,10, 6169-6185

Synthesis and evaluation of new polyenic compounds as potential PPARs modulators

D. Amans, V. Bellosta, C. Dacquet, A. Ktorza, N. Hennuyer, B. Staels, D. Caignard and J. Cossy, Org. Biomol. Chem., 2012, 10, 6169 DOI: 10.1039/C2OB25593F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements